₹ 23.10
0.43 (1.90%)
NSE
B
Balaxi Pharmaceuticals
₹ 23.10
NSE
BALAXI Financials Summary (Consolidated)
Balaxi Pharmaceuticals revenue increased 8.29% quarter-on-quarter to ₹80 Cr in Jun 2026, while net profit increased 116.67% quarter-on-quarter to ₹1 Cr. Compared to the same quarter last year, revenue is up 15.51% and net profit is up 333.33%. EPS for the quarter stood at ₹0.24, increased from ₹0.11 in the previous quarter and up from ₹0.05 a year ago.
Balaxi Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of BALAXI Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
BALAXI Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






